▲ Up
 
14:26 29-09-2016
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanKyrgyzstanMongoliaTajikistanTurkmenistanUzbekistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
14:07 Kazakh Ground Forces Commander in Chief appointed14:06 Central Election Commission says enough time to prepare for constitutional referendum13:51 Kyrgyz Finance Ministry proposes to reduce budget expenditures by 14.9 bn soms in 201613:46 South Korea to provide another $250 million to Uzbekistan13:38 Kyrgyzstan plans to start issuing electronic passports since late December13:27 Pakistan humiliated by four South Asian countries' boycott of SAARC meeting12:55 11 banks of Uzbekistan among top 200 banks in CIS — RIA Ranking12:49 Transport Minister takes part in ICAO World Aviation Forum in Montreal12:22 Astana to name one of its streets after Nikola Tesla12:12 Prime Minister of Serbia Aleksandar Vucic to visit Kazakhstan12:09 ADB keeps GDP growth forecast for Uzbekistan at 6.9% in 201612:07 Kyrgyzstan creates automated information system for veterinary and phytosanitary documentation11:56 Kyrgyzstan, Czech Republic can cooperate on green economy, agriculture, food processing: Minister11:48 Health Ministry concerned over lack of doctors in rural areas11:42 Law increasing fines for unlicensed banking activities in Kyrgyzstan 166-fold comes into force: Central bank11:34 MP asks government to pay compensation to Leilek residents whose houses were destroyed by floods11:33 MP asks government to give money for construction of canals in southern Kyrgyzstan11:29 92 industrial enterprises suspended in Kazakhstan for violation of environmental laws11:18 U.S. to send more troops to Iraq11:01 Joint statement on Meeting of Foreign Ministers of G4 countries on UN Security Council reform
Astana
+18° C
Ashgabat
+19° C
Bishkek
+28° C
Dushanbe
+28° C
Tashkent
+31° C
Ulaanbaatar
+11° C
exchange rates
 
76.43
68.15
10.27
1.07
377.83
336.99
50.51
5.27
6.85
6.26
1.01
0.12
3286.53
2888.39
446.81
42.81
3.93
3.50
0.52
0.05

© AKIpress News Agency - 2001-2016. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75